In this study, we utilized the TCGA and GEO databases combined with our clinical specimens to evaluate the expression of ADAM12 in ccRCC and its correlation with clinicopathological factors and clinical outcomes. The gene discussed is ADAM12; the disease is nonpapillary renal cell carcinoma.